"","neurotransmitter","uniqueID","Author","Year","doi","Include_final","design_true","N_drug","N_placebo","female_pct_drug","female_pct_pla","age_drug_m","age_drug_sd","age_pla_m","age_pla_sd","age_total","female_total","Drug","Dose","drug_interpretation","single_or_multiple_drugAdministrations","acute","taskAdministrationTime_postIntervention","repeatedMean_sessionTimewindow","task","task_name","task_name2","measure","outcome_name","t","F","exact_p","drug_m","drug_sd","drug_sem","placebo_m","placebo_sd","placebo_sem","MeanDiff","SED","d_raw","r_correlation","d.direction.new","Category","secondary_category","AuthorY","design","valence","author_provided_data","Random.sequence.generation","Allocation.concealment","Blinding.of.participants.and.experimenters","Blinding.of.outcome.assessment","Incomplete.outcome.data","drug_category","drug_activity","simplified_drug_target","drug_target","simplified_drug_target2","drug_dose","treat_as"
"1","DA",208,"Norbury",2013,"https://dx.doi.org/10.1523/JNEUROSCI.5587-12.2013","N need data incl w","w",20,20,0,0,"26.7","5.67","26.7","5.67","26.7","","cabergoline","1.5mg","increase_DA","single","1","2h","2 weeks","probabilistic choice task (risky decision making)","gambling","","overall proportion of choices of the “experimental” gamble","p(gamble)",0.72,NA,0.48,0.499020599,NA,NA,0.514458395,NA,NA,NA,NA,NA,NA,-1,"risk attitude","","Norbury, 2013","w","r","","H","H","L","L","H","upregulate dopamine","agonist","D2 receptor agonist ","D2 and D3 receptor agonist ","other","cabergoline 1.5mg","w"
"2","DA",125,"Hirschbichler",2022,"https://dx.doi.org/10.1007/s00221-022-06501-9","Y","w",30,30,0.53,0.53,"31.67","12.34","31.67","12.34","31.67","0.53","L-dopa","100mg","increase_DA","single","1","1h","at least 1 week","gambling task (same as Rogers et al 2003, Murphy et al 2009)","gambling","","the proportion of risky choices (trials when the experimental gamble was chosen)","p(gamble)",3.26860823359343,12.29,NA,0.5078125,0.143484457699408,NA,0.430729166666667,0.158054415837271,NA,NA,NA,NA,0.636826726816856,1,"risk attitude","","Hirschbichler, 2022","w","r","yes","H","H","?","L","L","upregulate dopamine","agonist","DA precursor","DA precursor","DA precursor","L-dopa 100mg","w"
"3","DA",228,"Rigoli",2016,"https://dx.doi.org/10.1038/npp.2016.68","Y","w",32,32,0.5,0.5,"23.4","4.7","23.4","4.7","23.4","0.5","L-dopa","150mg+37.5mg","increase_DA","single","1","45 min","3 to 11 days apart","gambling task","gambling","","Average gambling","p(gamble)",1.23273132867631,1.66,0.208,48.0339382975977,22.5223051792184,NA,45.2900976966874,23.0372614225057,NA,NA,NA,NA,0.847478824423865,1,"risk attitude","","Rigoli, 2016","w","r","yes","H","L","L","L","L","upregulate dopamine","agonist","DA precursor","DA precursor","DA precursor","L-dopa 150mg+37.5mg","w"
"4","DA",238,"Rutledge",2015,"https://dx.doi.org/10.1523/JNEUROSCI.0702-15.2015","Y","w",30,30,0.63,0.63,"23.4","3.8","23.4","3.8","23.4","0.63","L-dopa","150mg+37.5mg","increase_DA","single","1","60 min","1 week","gambling task","gambling","","arcsined gamble choice in gain trials","p(gamble) gain",2.41454187621418,NA,NA,2.13172172398207,0.431939753667606,3.1,1.99900421862958,0.410682720246161,3.1,NA,NA,NA,0.745798530810294,1,"risk attitude","","Rutledge, 2015","w","r","yes","H","H","L","L","L","upregulate dopamine","agonist","DA precursor","DA precursor","DA precursor","L-dopa 150mg+37.5mg","w"
"5","DA",227,"Riba",2008,"https://dx.doi.org/10.1371/journal.pone.0002479","N need data incl w","w",15,15,0,0,"24.4",NA,"24.4",NA,"24.4","","pramipexole","0.5mg","increase_DA","single","1",NA,"at least 1 week","a lottery task","gambling","","The probability of making “risky” choices","p(risky choice)",1,NA,0.33,0.49,NA,NA,0.47,NA,NA,NA,NA,NA,NA,1,"risk attitude","","Riba, 2008","w","r","","H","H","L","L","H","upregulate dopamine","agonist","D2 receptor agonist ","D2 and D3 receptor agonist ","other","pramipexole 0.5mg","w"
